Preliminary study on radioimmunodiagnosis of experimental tumor models using technetium-99m-labeled anti-C-erbB-2 monoclonal antibody

Tumori

Volumn 88, Issue 6, 2002, Pages 507-512

  Meenakshi, Ananthanarayanan ^a   Suresh Kumar, Rayala ^a   Ganesh, Venkatraman ^a   Siva Kumar, Nallathambi ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

C erbB 2; Immunoscintigraphy; MAb CIBCgp185; Technetium 99m

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CIBCGP185; ONCOPROTEIN; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER LOCALIZATION; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSCINTIGRAPHY; MOUSE; NONHUMAN; NUDE MOUSE; SCINTILLATION CAMERA; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

EID: 0036879975     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800615     Document Type: Article

References (23)

1. Sigrid S, Maths I, Anders L, Lars H, Bergh J: Prognostic and predictive value of C-erbB-2 overexpression in primary breast cancer alone or in combination with other prognostic markers. J Clin Oncol, 16: 462-469, 1998.
2. Britton KE, Granowska M: Immunoscintigraphy. Acta Oncol, 35: 313-317, 1996.
3. Digvi CR: Status of radiolabelled monoclonal antibodies for diagnosis and therapy of cancer. Oncology, 10: 939-953, 1996.
4. Granowska M, Mather SJ, Britton KE, Bentley S, Richman P, Philips RK, Northover JM: 99mTc radioimmunoscintigraphy of colorectal cancer. Br J Cancer, 10: 30-33, 1990.
5. Akiyama T, Sudo C, Ogawara M, Toyoshima K, Yamamoto T: The product of the C-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science, 232: 1644-1646, 1986.
6. Meenakshi A, SureshKumar R, SivaKumar N: Generation of monoclonal antibody CIBCgp185 against C-erbB-2 oncoprotein and its clinical evaluation. Human Antibodies, 10: 101-107, 2001.
7. Ross JS, Fletcher JA: The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Oncologist, 3: 237-252, 1998.
8. Lietzel K, Teramoto Y, Konrad K, Chinchilli VM, Volas G, Grossberg H, Harvey H, Demers L, Lipton A: Elevated serum antigen levels and decreased response to hormone therapy of breast cancer. J Clin Oncol, 13: 1129-1135, 1995.
9. Perren TJ: C-erbB-2 oncogene as a prognostic marker in breast cancer. Br J Cancer, 63: 328-332, 1991.
10. Meenakshi A, Suresh Kumar R, Siva Kumar N: ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients. J Immunoassay Immunochem, 23: 293-305, 2002.
11. Mather SJ, Ellison D: Reduction-mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med, 31: 692-697, 1990.
12. Lindmo T, Bunn P: Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabelling. Methods Enzymol, 121: 679-691, 1986.
13. Rakesh Chopra: Breast cancer: the Indian scene. J Clin Oncol, 19: 106-111, 2001.
14. Pinkas L, Robins PD, Forstrom LA, Mahoney DW, Mullan BP: Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature. Nucl Med Commun, 20: 689-696, 1999.
15. Hanna W, Kahn HJ, Andrulis I, Pawson T: Distribution and pattern of staining of neu oncogene product in benign and malignant breast diseases. Mod Pathol, 3: 455-461, 1990.
16. Press MF, Cordon-Cardo C, Slamon DJ: Expression of the HER2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene, 5: 953-962, 1990.
17. Dillman RO: Perceptions of Herceptin: a monoclonal antibody for the treatment of breast cancer. Cancer Biother Radiopharm, 14: 5-10, 1999.
18. Dean CJ, Eccles SA, Valeri M, Box G, Allan S, McFarlane C, Sandle J, Styles J: Rat MAbs to the product of the C-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer. Cell Biophys, 22: 111-127, 1993.
19. Sakamoto G, Mitsuyama S: New molecule-targeting therapy with herceptin (trastuzumab), an anti-HER-2 (C-erbB-2) monoclonal antibody. Breast Cancer, 7: 350-357, 2000.
20. Allan SM, Dean CJ, Eccles S, Sacks NP: Clinical radioimmunolocalization with a rat monoclonal antibody directed against C-erbB-2. Cell Biophys, 24-25: 93-98, 1994.
21. Allan SM, Dean CJ, Fernando I, Eccles S, Styles J, McCready VR, Baum M, Sacks N: Radioimmunolocalisation in breast cancer using the gene product of C-erbB-2 as the target antigen. Br J Cancer, 67: 706-712, 1993.
22. Dean CJ, Allan S, Eccles S, McFarland C, Styles J, Valeri M, Sandle J, Bakir A, Sacks N: The product of the C-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer. Year Immunol, 7:182-192, 1993.
23. Vulliez JP: Immunoscintigraphy in oncology. Rev Med Interne, 16: 833-842, 1995.